Biotech Struggles to Recover in 2024November 5, 2024by Adam O'DellBanyan Edge, Investment Opportunities, StocksBiotech valuations and investing peaked in late 2021, with investors surging into the sector at the height of the Covid-19 pandemic. Interest in the sector waned over the last few years — due in part to sharply increased interest rates and the rapid emergence of the AI mega trend. But now, the smart money is starting to flow back into the
sector...
Newsletter Sign Up
Subscribe to our Banyan Edge newsletter to get financial insights and tips from our top investment experts. Start investing with an edge today!
Get the best of Banyan Hill, straight to your inbox today for FREE!